000 | 01853 a2200517 4500 | ||
---|---|---|---|
005 | 20250514064322.0 | ||
264 | 0 | _c20030613 | |
008 | 200306s 0 0 eng d | ||
022 | _a0300-0664 | ||
024 | 7 |
_a10.1046/j.1365-2265.2003.01759.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIsidori, A M | |
245 | 0 | 0 |
_aThe effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. _h[electronic resource] |
260 |
_bClinical endocrinology _cMay 2003 |
||
300 |
_a601-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xdeficiency |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAndrogens _xmetabolism |
650 | 0 | 4 |
_aAndrostenedione _xblood |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 | _aBody Weight |
650 | 0 | 4 |
_aCarrier Proteins _xblood |
650 | 0 | 4 |
_aDehydroepiandrosterone Sulfate _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGonadal Steroid Hormones _xtherapeutic use |
650 | 0 | 4 |
_aGrowth Substances _xblood |
650 | 0 | 4 |
_aHormone Replacement Therapy _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xtherapeutic use |
650 | 0 | 4 |
_aHypopituitarism _xdrug therapy |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRadioimmunoassay _xmethods |
650 | 0 | 4 |
_aSex Hormone-Binding Globulin _xanalysis |
650 | 0 | 4 |
_aTestosterone _xblood |
700 | 1 | _aKaltsas, G A | |
700 | 1 | _aPerry, L | |
700 | 1 | _aBurrin, J M | |
700 | 1 | _aBesser, G M | |
700 | 1 | _aMonson, J P | |
773 | 0 |
_tClinical endocrinology _gvol. 58 _gno. 5 _gp. 601-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2265.2003.01759.x _zAvailable from publisher's website |
999 |
_c12491087 _d12491087 |